Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-α, and IL-1β

GLIA

Volumn 53, Issue 3, 2006, Pages 304-312

  Zhao, Jie ^a,b   Brooks, Diane M ^a   Lurie, Diana I ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ERK; MAP kinase; Neurotoxic, phosphatase; p38

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN INDUCING KINASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN STEM; CELL ACTIVATION; CELL LOSS; COCHLEA INJURY; CONTROLLED STUDY; DEAFFERENTATION; DEGENERATIVE DISEASE; ENZYME DEFICIENCY; INFECTION; INJURY; MEDIATOR RELEASE; MICROGLIA; MOUSE; MOUSE STRAIN; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN STEM; CELL DEATH; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENOTYPE; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; MICE, NEUROLOGIC MUTANTS; MICROGLIA; NERVE TISSUE PROTEINS; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHP1 PROTEIN TYROSINE PHOSPHATASE; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 32344434399     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20283     Document Type: Article

References (60)

1. Akama KT, Van Eldik LJ. 2000. Beta-amyloid stimulation of inducible nitric oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNF-alpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275:7918-7924.
2. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480-6491.
3. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7:111-118.
4. Barger SW, Basile AS. 2001. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 76:846-854.
5. Basu A, Krady JK, Enterline JR, Levison SW. 2002a. Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia 40:109-120.
6. Basu A, Krady JK, O'Malley M, Styren SD, DeKosky ST, Levison SW. 2002b. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci 22:6071-6082.
7. Bhat NR, Fan F. 2002. Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways. Brain Res 948:93-101.
8. Bhat NR, Zhang P, Lee JC, Hogan EL. 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641.
9. Chao CC, Hu S, Ehrlich L, Peterson PK. 1995. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9:355-365.
10. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736-2741.
11. Chein HF, Yeh KY, Jiang-shieh YF, Wei IH, Chang CY, Wu CH. 2005. Signal transduction pathways of nitric oxide release in primary microglial cultures challenged with gram-positive bacterial constituent, lipoteichoic acid. Neuroscience 133:423-436.
12. David M, Chen HE, Goelz S, Larner AC, Neel BG. 1995. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 15:7050-7058.
13. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
14. Dong Q, Siminovitch KA, Fialkow L, Fukushima T, Downey GP. 1999. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1. J Immunol 162:3220-3230.
15. Duchesne C, Charland S, Asselin C, Nahmias C, Rivard N. 2003. Negative regulation of beta-catenin signaling by tyrosine phosphatase SHP-1 in intestinal epithelial cells. J Biol Chem 278:14274-14283.
16. Eskes C, Juillerat-Jeanneret L, Leuba G, Honegger P, Monnet-Tschudi F. 2003. Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J Neurosci Res 71:583-590.
17. Eyupoglu IY, Bechmann I, Nitsch R. 2003. Modification of microglia function protects from lesion-induced neuronal alterations and promotes sprouting in the hippocampus. FASEB J 17:1110-1111.
18. Gazzinelli RT, Eltoum I, Wynn TA, Sher A. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 151:3672-3681.
19. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann KA, Kreutzberg GW. 1992. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 12:257-269.
20. Gehrmann J, Banati RB, Wiessner C, Hossmann KA, Kreutzberg GW. 1995. Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol Appl Neurobiol 21:277-289.
21. Griffin WS, Mrak RE. 2002. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 72:233-238.
22. Han IO, Kim KW, Ryu JH, Kim WK. 2002. p38 mitogen-activated protein kinase mediates lipopolysaccharide, not interferon-gamma, -induced inducible nitric oxide synthase expression in mouse BV2 microglial cells. Neurosci Lett 325:9-12.
23. Haque SJ, Harbor P, Tabrizi M, Yi T, Williams BR. 1998. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem 273:33893-33896.
24. Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP. 2003. The role of glial reaction and inflammation in Parkinson's disease. Ann NY Acad Sci 991:214-228.
25. Hsu HC, Shultz LD, Su X, Shi J, Yang PA, Relyea MJ, Zhang HG, Mountz JD. 2001. Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice. J Immunol 166:772-780.
26. Jan SB, Won J, Kim H, Kim J, Lee KH, Han H, Rha HK, Choi CR. 2002. TAK1 mediates lipopolysaccharide-induced RANTES promoter activation in BV-2 microglial cells. Mol Cells. 14:35-42.
27. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS. 1998. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10.
28. Kalla R, Liu Z, Xu S, Koppius A, Imai Y, Kloss CU, Kohsaka S, Gschwendtner A, Moller JC, Werner A and others. 2001. Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice. J Comp Neurol 436:182-201.
29. Kim JM, Oh YK, Lee JH, IM DY, Kim YJ, Youn J, Lee CH, Son H, Lee YS, Park JY, Choi IH. 2005. Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK, and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli. Clin Exp Immunol 140:450-460.
30. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
31. Kuno R, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. 2005. Autocrine activation of microglia by tumor necrosis factor-α. J Neuroimmunol 162:89-96.
32. Lehtonen JY, Daviet L, Nahmias C, Horiuchi M, Dzau VJ. 1999. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis. Mol Endocrinol 13:1051-1060.
33. Liu B, Hong JS. 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1-7.
34. Lurie DI, Solca F, Fischer EH, Rubel EW. 2000. Tyrosine phosphatase SHP-1 immunoreactivity increases in a subset of astrocytes following deafferentation of the chicken auditory brainstem. J Comp Neurol 421:199-214.
35. Ma XC, Gottschall PE, Chen LT, Wiranowska M, Phelps CP. 2002. Role and mechanisms of interleukin-1 in the modulation of neurotoxicity. Neuroimmunomodulation 10:199-207.
36. Massa PT, Saha S, Wu C, Jarosinski KW. 2000. Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes. Glia 29:376-385.
37. Massa PT, Wu C. 1998. Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J Interferon Cytokine Res 18:499-507.
38. Medana IM, Hunt NH, Chan-Ling T. 1997. Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia 19:91-103.
39. Mostafapour SP, Cochran SL, Del Puerto NM, Rubel EW. 2000. Patterns of cell death in mouse anteroventral cochlear nucleus neurons after unilateral cochlea removal. J Comp Neurol 426:561-571.
40. Mostafapour SP, Del Puerto NM, Rubel EW. 2002. bcl-2 Overexpression eliminates deprivation-induced cell death of brainstem auditory neurons. J Neurosci 22:4670-4674.
41. Nelson PT, Soma LA, Lavi E. 2002. Microglia in diseases of the central nervous system. Ann Med 34:491-500.
42. Neznanov N, Neznanova L, Kondratov RV, O'Rourke DM, Ullrich A, Gudkov AV. 2004. The ability of protein tyrosine phosphatase SHP-1 to suppress NFkappaB can be inhibited by dominant negative mutant of SIRPalpha. DNA Cell Biol 23:175-182.
43. Nicholas RS, Compston A, Brown DR. 2001. Inhibition of tumour necrosis factor-alpha (TNFalpha)-induced NF-kappaB p52 converts the metabolic effects of microglial-derived TNFalpha on mouse cerebellar neurones to neurotoxicity. J Neurochem 76:1431-1438.
44. Paris D, Town T, Mullan M. 2000. Novel strategies for opposing murine microglial activation. Neurosci Lett 278:5-8.
45. Park SY, Lee H, Hur J, Kim SY, Kim H, Park JH, Cha S, Kang SS, Cho GJ, Choi WS, Suk K. 2002. Hypoxia induces nitric oxide production in mouse microglia via p38 mitogen-activated protein kinase pathway. Brain Res Mol Brain Res 107:9-16.
46. Peterson PK, Hu S, Anderson WR, Chao CC. 1994. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 170:457-460.
47. Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN. 2002. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 83:754-763.
48. Ramakrishnan P, Wang W, Wallach D. 2004. Receptor-specific signaling for both the alternative and the canonical ND-kb activation pathways by NF-Kb-inducing kinase. Immunity 21:477-489.
49. Saxena M, Williams S, Gilman J, Mustelin T. 1998. Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP). J Biol Chem 273:15340-15344.
50. Shibasaki Y, Matsubara H, Nozawa Y, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T. 2001. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase. Hypertension 38:367-372.
51. Shultz LD, Green MC. 1976. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J Immunol 116:936-943.
52. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454.
53. Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP 2002. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J 16:1474-1476.
54. Suo Z, Wu M, Ameenuddin S, Anderson HE, Zoloty JE, Citron BA, Andrade-Gordon P, Festoff BW. 2002. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem 80:655-666.
55. Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN, Bertics PJ. 2002. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem 277:9077-9087.
56. Wishcamper CA, Brooks DM, Douglas Coffin J, Lurie DI. 2003. Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice. Brain Res 974:88-98.
57. Yi TL, Cleveland JL, Ihle JN. 1992. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol 12:836-846.
58. You M, Flick LM, Yu D, Feng GS. 2001. Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J Exp Med 193:101-110.
59. Zhang Z, Jimi E, Bothwell AL. 2003. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J Immunol 171:3620-3626.
60. Zhao J, Lurie DI. 2004. Cochlear ablation in mice lacking SHP-1 results in an extended period of cell death of anteroventral cochlear nucleus neurons. Hear Res 189:63-75.